Yahoo Finance

VS3 Medical Announces First Patients Enrolled in First-in-Human Study of Novel Neurovascular Implant to Address Symptomatic Venous Sinus Stenosis

SAN JOSE, Calif., March 09, 2026--(BUSINESS WIRE)--VS3 Medical, Inc., a private company developing novel neurovascular implants, today announced it has commenced enrollment in its international ...
WLNS.com

Serenity Medical Announces Clinical Publication of First Prospective Multicenter Trial of the River™ Stent, a Novel Venous Sinus Stent for Treating Idiopathic Intracranial ...

HARRISON, N.Y., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Serenity Medical, a NeuroTechnology Investors (NTI) portfolio company dedicated to the treatment of venous sinus stenosis, today announced the ...
manilatimes

Serenity Medical Receives U.S. FDA HDE Approval of the River™ Stent - the First Venous Stent Approved for Severe, Refractory Idiopathic Intracranial Hypertension (IIH)

Landmark regulatory milestone makes the River stent available for adults with severe IIH - a debilitating, historically undertreated condition - who have failed medical therapy Serenity Medical ...
Yahoo Finance

Sonorous Neurovascular Receives FDA Breakthrough Device Designation for BosSTENT™, First Braided Self-Expanding Cerebral Venous Stent, to Treat Debilitating Pulsatile Tinnitus

LAKE FOREST, Calif., Feb. 5, 2026 /PRNewswire/ -- Sonorous Neurovascular, a pioneering medical device company dedicated to advancing neurovascular therapies, today announced that the U.S. Food and ...
Pharmabiz

VS3 Medical begins patient enrollment in FIH study of novel neurovascular implant to address symptomatic venous sinus stenosis

VS3 Medical, Inc., a private company developing novel neurovascular implants, announced it has commenced enrollment in its international first-in-human (FIH) study evaluating its VS3 Medical Stent ...
MarketWatch

Serenity Medical Receives U.S. FDA HDE Approval of the River(TM) Stent - the First Venous Stent Approved for Severe, Refractory Idiopathic Intracranial Hypertension (IIH)

The MarketWatch News Department was not involved in the creation of this content. Landmark regulatory milestone makes the River stent available for adults with severe IIH -- a debilitating, ...